The role of cost-effectiveness analysis in assessing HIV-prevention interventions.
Department of Epidemiology and Biostatistics, University of California, San Francisco, USA.
J G
JG
Kahn
K C
KC
Sanstad
D015492:AIDS Serodiagnosis / Q000191:economics*; D003362:Cost-Benefit Analysis; D003657:Decision Making; D015658:HIV Infections / Q000191:economics / Q000517:prevention & control*; D006282:Health Personnel / Q000193:education*; D006801:Humans; D018803:Models, Economic; D018671:Needle-Exchange Programs / Q000191:economics*; D010820:Physicians; D012309:Risk-Taking